This is the question the rest of the internet answers with a single cheerful word, and the single cheerful word is wrong. The default position in IRS Pub. 502 is that vitamins, herbal supplements and "natural medicines" are not includible medical expenses. There is an exception, it is narrow, and it has two halves that get collapsed into one constantly.
Pub. 502: you can’t include the cost of nutritional supplements, vitamins, herbal supplements or "natural medicines" unless they are recommended by a medical practitioner as treatment for a specific medical condition diagnosed by a physician. That is a narrow exception to a prohibition — not a green light.
Custodians almost always auto-approve these, but no IRS document names prenatal vitamins. Under Pub. 502’s literal text they are vitamins and need a letter. Prescription prenatals are separately eligible as prescribed drugs. Label this "usually reimbursed", not "eligible".
The clearest case of industry convention outrunning the law. No statute, reg, notice, publication or IRS FAQ mentions glucosamine or chondroitin. Custodians code them auto-eligible anyway. Convenient, but it is convention — not authority you could cite in an audit.
Turns on the label panel, not the ingredient. A Drug Facts panel (bulk laxative, e.g. Metamucil) rides the OTC-drug rule and is reimbursable. A Supplement Facts panel (fiber gummies, "prebiotic fiber") is a supplement and needs a letter. Same psyllium, two answers.
Classification is at the expense-category level, comes from this project's HSA reference data, and is not a Magellan determination about any individual product. Your plan administrator decides what your plan reimburses.
Read the sentence slowly. A practitioner has to recommend the supplement as treatment, and a physician has to have diagnosed a specific condition for it to treat. Both halves, not either half. "My doctor said magnesium is fine" is not a recommendation as treatment. "I take berberine to optimise my metabolic health" names no diagnosed condition. Neither one gets you across.
The practical consequence is uncomfortable for a catalogue like this one: the strength of the evidence behind a supplement has nothing whatsoever to do with its tax status. Creatine has one of the deepest human evidence bases of anything on this site and it is still, for Pub. 502 purposes, a supplement sitting behind the default prohibition. An evidence grade is not a tax classification, and the two are not correlated.
Glucosamine and chondroitin are the clearest case in the whole reference set. No statute, regulation, notice, publication or IRS FAQ mentions either compound. Custodians code them auto-eligible anyway — so the card goes through, the claim clears, and nothing you could cite in an audit ever existed. That is a convenience, not an authority, and the reference data labels it as such rather than rounding it up to "eligible".
Prenatal vitamins run the same way: near-universal auto-approval, no IRS document naming them. Prescription prenatals are a separate matter — they are eligible as prescribed drugs, which is a different rule reaching a friendlier answer.
Fiber is the single most useful example on this page, because it shows that the same molecule can land in two different tax buckets depending on how the manufacturer printed the box. A product with a Drug Facts panel — a bulk laxative — rides the over-the-counter drug rule and is reimbursable without a letter. A product with a Supplement Facts panel — fiber gummies, "prebiotic fiber" — is a supplement and falls back to the letter requirement. Same psyllium. Two answers.
So when you are deciding, look at the actual tub in your hand rather than the category on a website. And if you are buying for the physiology rather than the reimbursement, the evidence pages are the better read: fiber and inulin.
Every supplement in this catalogue sits in the same expense category the reference data classifies above — the classification is at the category level and is not a determination about any individual product. Magellan does not decide what your plan reimburses; the products below are linked for their evidence, not for their tax status.
23 PubMed citations · $44
Across meta-analyses and randomized trials, creatine monohydrate combined with resistance…
22 PubMed citations · $33.75
Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…
24 PubMed citations · $18.95
Evidence on glucosamine for aging-related joint health is genuinely mixed: in the landmark…
24 PubMed citations · $13.79
Evidence on glucosamine and chondroitin for osteoarthritis is large but genuinely mixed. The…
25 PubMed citations · $32.99
The evidence for glucosamine and chondroitin in human osteoarthritis is genuinely mixed. The…
21 PubMed citations · $27.99
Randomized trials and meta-analyses indicate that inulin-type fructans reliably increase…
This is the one category where a letter genuinely changes an outcome — because the rules already leave room for it. It does not create room where none exists. See what a Letter of Medical Necessity is and is not.
Whatever the category, three limits hold on every letter:
What the IRS documents say, what custodians actually do, and the three questions hiding inside "is it eligible?"
All fifteen expense categories scored against the three tests, with the citation behind each one.
A dated, printable spend-down plan — and the trap the internet tells you to walk into every December.
Twenty-two questions with the citation attached to each answer.
What one is, the six fields administrators look for, and the three things a letter cannot do.
Log purchases in the Magellan HSA / FSA ledger →